The global Nasopharyngeal Cancer market is anticipated to grow at a modest CAGR of around 2.6% during the forecast period (2021-2027). Nasopharyngeal cancer is a disease in which malignant (cancer) cells form in the tissues of the nasopharynx, which is the upper part of the pharynx (throat) behind the nose. According to the American Institute for Cancer Research, it is the 23rd most common cancer worldwide, and in 2018, Brunei (9.9 in 100,000) had the highest rate of nasopharyngeal cancer geographically. The rising prevalence rates of nasopharyngeal cancer, the growing geriatric population, and the high consumption of tobacco and alcohol are the major factors that are driving the growth of the global nasopharyngeal cancer market. The main cause of the rising incidence of this cancer is the lack of awareness about this cancer and treatments among the common population. Moreover, according to the Health Protection Center, nasopharyngeal cancer is more common in the southern part of China than in Western countries. Furthermore, in 2018, NPC caused 295 deaths, which was 2% of the total cancer deaths according to the same. Whereas, the NPC is uncommon in the US, as per the American Society of Clinical Oncology (ASCO), in the US, less than 1 person out of 100,000 people is diagnosed with NPC each year. So it is expected that the market will grow in the Asia-Pacific region, especially in Southeast Asia (Thailand, Vietnam, Indonesia, Malaysia, and Singapore).
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/nasopharyngeal-cancer-market
The high cost of nasopharyngeal cancer treatments is the factor that may hamper the growth of the market. The advancement in new technology and cost-effective treatments may be expected to increase market growth in upcoming years. Furthermore, government awareness programs and investments for R&D activities can create lucrative opportunities in the global nasopharyngeal cancer market during the forecast period.
A Full Report of Global Nasopharyngeal Cancer Market is Available at: https://www.omrglobal.com/industry-reports/nasopharyngeal-cancer-market
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Nasopharyngeal Cancer Market Report Segment
By Cancer Type
- Keratinising Squamous Cell Carcinoma
- Non-Keratinising Squamous Cell Carcinoma
- Undifferentiated Carcinomas
- Other (Adenocarcinoma and Adenoid Cystic Carcinomas)
By Diagnosis Method
- Initial Diagnosis
o Nasendoscopy
o Panendoscopy
o Fine Needle Aspiration/Needle Biopsy
- Advanced Diagnosis
o CT Scan
o PET Scan
o MRI Scan
o Bone Scan
By Therapy
- Chemotherapy
- Immunotherapy
- Radiation Therapy
- Targeted Therapy
- Surgery
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
